Collaboration between academia, manufacturers and healthcare services for development and adoption of medical devices with regard to costs and effects
2009 (English)In: IFMBE World Congress on Medical Physics and Biomedical Engineering, München: Springer , 2009, 138-140 p.Conference paper (Refereed)
The market for new medical devices depends on evidence on effectiveness and cost-effectiveness as well as ethical criteria based on patients needs and severity of disease. HTA is therefore increasingly used to provide appraisals for decision makers. In comparison to pharmaceuticals, medical devices face difficulties in providing studies with high evidence. There are, however, new promising developments in health economics and in the systems for valuing evidence which may improve the possibility of quicker appraisal of medical devices. This development, comprising Bayesian modeling and revision of systems for grading evidence, may be used in an iterative procedure to anticipate the market potential and to contribute to finding an optimal time when the implementation of a new device is worthwhile. In such a system, researches, developers and manufacturers, and healthcare services should gain from strengthened collaboration.
Place, publisher, year, edition, pages
München: Springer , 2009. 138-140 p.
, WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT 12, ISSN 1680-0737
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-21820DOI: 10.1007/978-3-642-03893-8_39ISI: 000282043300039ISBN: 978-3-642-03892-1 (print)ISBN: 978-3-642-03893-8 (online)OAI: oai:DiVA.org:liu-21820DiVA: diva2:241768
World Congress on Medical Physics and Biomedical Engineering1: General Subjects; Munich; Germany